Karkinos Healthcare raises funds from Endiya Partners
Distributed cancer care startup Karkinos Healthcare has raised an undisclosed amount of funding from leading venture capitalist Endiya Partners.
“The investment in Karkinos Healthcare is a strong validation of our pioneering efforts to create a distributed cancer care network and we are thrilled to have Endiya Partners as a partner in our crusade against cancer,” said R Venkataramanan, Founder and CEO, Karkinos Healthcare, while commenting about the investment.
“Innovative tech startups in the cancer care space that help drive quality diagnostics and treatment to a larger number of patients is the need of the hour in India. We strongly feel Karkinos Healthcare with its comprehensive tech-led solutions and distributed network is poised to bring about the much-needed disruption in the cancer-care eco-system,” commented Dr. Ramesh Byrapeneni, Managing Director, Endiya Partners.
Founded by a highly experienced team, Karkinos Healthcare started its operations in Kerala, and is looking to expand to Tamil Nadu, Maharashtra, Karnataka and West Bengal. The company works with multiple healthcare institutions and professionals in the oncology ecosystem, successfully bringing cancer care closer to patients backed by a robust technology platform. It has also set up a Centre for Advanced Cancer Diagnostics in Kochi, to provide world-class diagnostic services, including molecular tests and immunohistochemistry tests, for cancer.
About Endiya Partners
Endiya Partners is an early-stage venture capital fund that invests in IP led product startups that are globally relevant. Endiya’s portfolio consists of disruptive and category-defining companies across Digital Transformation & Healthcare sectors. Leveraging deep domain expertise along with vast entrepreneurial and operating experience, the Endiya team plays a key role in co-creating scalable businesses while bridging a funding gap between Angel and Series A investments in the venture capital spectrum of India.
Endiya’s current portfolio includes AlphaICs, Cell Propulsion, Curefit, Cygni, Darwinbox, eKincare, Eyestem, Grip Invest, Gigforce, Kissht, Myelin Foundry, Qapita, SigTuple, Slang Labs, Steradian, SuperBeings, Synapsica, Upside AI and Zluri.
Endiya Team has successfully invested and exited companies like Little Eye Labs (Facebook), StyleCraze (istyle – Japan), and ShieldSquare (Radware – Israel).
About Karkinos Healthcare
Karkinos Healthcare Pvt. Ltd. is an India-based digital oncology startup focused on designing and delivering bespoke solutions for cancer care. The company is on a mission to create ‘cancer centers without walls’ with a primary aim of addressing the lack of access or affordability in cancer care.
The rate of new cancer cases diagnosed in India, which is estimated to be presently at 2.25 million per year, is expected to double in the coming years. And three quarters of these cancers are detected only in the late stages with devastatingly high mortality rates due to lack of access to standardized cancer care. Karkinos Healthcare intends to change this scenario with community-focussed early screening programs and personalized treatment interventions thereby taking cancer care closer to the home of the citizen or patient.
The company’s motto is to deliver seamless patient experiences through an effective patient navigation-based system that offers digitally-supported care pathways and services ranging from early detection, diagnosis, surgery, chemotherapy, and palliative care.
News in various publications
- Express Healthcare: Karkinos Healthcare raises funds from Endiya Partners – Express Healthcare
- BioSpectrum India: Karkinos Healthcare raises funds from Endiya Partners (biospectrumindia.com)